These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dantrolene sodium: long-term effects in severe spasticity. Chyatte SB, Basmajian JV. Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936 [No Abstract] [Full Text] [Related]
3. Dantrolene sodium in children with spasticity. Haslam RH, Walcher JR, Lietman PS, Kallman CH, Mellits ED. Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292 [No Abstract] [Full Text] [Related]
4. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium). Dykes MH. JAMA; 1975 Feb 24; 231(8):862-4. PubMed ID: 1089167 [Abstract] [Full Text] [Related]
5. Spasticity and the effect of dantrolene sodium. Monster AW. Arch Phys Med Rehabil; 1974 Aug 24; 55(8):373-83. PubMed ID: 4605132 [No Abstract] [Full Text] [Related]
6. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity]. Ladd HW, Gingras G, Boucher J, Kazdan N, Keenan R. Union Med Can; 1973 May 24; 102(5):1087-92. PubMed ID: 4576244 [No Abstract] [Full Text] [Related]
7. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit. Prescrire Int; 2008 Dec 24; 17(98):237. PubMed ID: 19422149 [Abstract] [Full Text] [Related]
11. Dantrolene sodium: long-term effects in patients with muscle spasticity. Joynt RL. Arch Phys Med Rehabil; 1976 May 19; 57(5):212-7. PubMed ID: 776122 [Abstract] [Full Text] [Related]
12. [4261 CB (tetrazepam) in the treatment of cerebral palsy. Introduction to the study of the drug and of its action]. Grimaud P, Chevrier J. Sem Hop; 1971 Mar 26; 47(15):953-9. PubMed ID: 4324376 [No Abstract] [Full Text] [Related]
13. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm]. Couto B, Figuereido HB, Araújo Leitão RE, Alvarenga H, Gomes Marleide M, Melo Reis CH. Neurol Neurocir Psiquiatr; 1976 Mar 26; 17(4):213-21. PubMed ID: 1018726 [Abstract] [Full Text] [Related]
14. The effect of dantrolene sodium on spasticity in multiple sclerosis. Gelenberg AJ, Poskanzer DC. Neurology; 1973 Dec 26; 23(12):1313-5. PubMed ID: 4796610 [No Abstract] [Full Text] [Related]
15. Treatment of spastic cerebral-palsied children with sodium dantrolene. Denhoff E, Feldman S, Smith MG, Litchman H, Holden W. Dev Med Child Neurol; 1975 Dec 26; 17(6):736-42. PubMed ID: 1107103 [No Abstract] [Full Text] [Related]
16. Cooperative study for assessing the effects of a pharmacological agent on spasticity. Monster AW, Herman R, Meeks S, McHenry J. Am J Phys Med; 1973 Aug 26; 52(4):163-88. PubMed ID: 4722384 [No Abstract] [Full Text] [Related]
17. Efficacy of dantrolene sodium in the treatment of spasticity. Chipman M, Kaul S, Lambie M. Dis Nerv Syst; 1974 Sep 26; 35(9):427-31. PubMed ID: 17894068 [Abstract] [Full Text] [Related]
18. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Joynt RL, Leonard JA. Dev Med Child Neurol; 1980 Dec 26; 22(6):755-67. PubMed ID: 7004956 [Abstract] [Full Text] [Related]
19. Pharmacology of dantrolene sodium in children. Lietman PS, Haslam RH, Walcher JR. Arch Phys Med Rehabil; 1974 Aug 26; 55(8):388-92. PubMed ID: 4853611 [No Abstract] [Full Text] [Related]
20. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Glass A, Hannah A. Paraplegia; 1974 Nov 26; 12(3):170-4. PubMed ID: 4616209 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]